Treat your diabetes patients with expert precision.
These go-to educational assets cover the broad spectrum of diabetes care, from the latest breaking news covering clinical research outcomes, to gold-standard clinical practice guidelines and treatment recommendations.
Topics covered include
If you're interested in diabetes, you may enjoy episode 5 of the new AACE Podcasts.
A 78 year old male presents to endocrine clinic for diabetes evaluation after recent hospital stay for a heart failure exacerbation. His past medical history is significant for ESRD on hemodialysis, HFrEF with an EF of 35%, CAD s/p multiple stents, COPD on home O2, hypertension, and hyperlipidemia.
His diabetes medication regimen is presently lantus 20 units qHS, lispro 7 units TID AC, and glipizide XL 10mg qday.
A 45 year old male with type 2 diabetes comes to see his endocrinologist. His Hba1c had been 6.7 last visit 6 months back. HIs A1c has now has gone up to 8.2 on recent labs. He is currently on metformin 1000mg bid. The patient had been following carb counting but has been non-compliant with his diet lately. He reports fasting glucose in 150-230 range most days. He checks before dinner occasionally and reports glucose usually over 200. He denies any hypoglycemia.
Michael is a 48-year-old gentleman with T2DM since age of 38. He has background of ischemic heart disease, mixed hyperlipidemia and hypertension. He had a delayed presentation of an inferior myocardial infarction 3 months ago. He is currently treated with Metformin XR 1g twice daily, Sitagliptin 100mg once daily, perindopril 5mg once daily, bisoprolol 2.5mg once daily Atorvastatin 80mg once daily. His most recent labs showed:
Our updated guideline for the care and management of people with or at risk for diabetes mellitus. The guideline features 170 updated and new evidence-based clinical practice recommendations for diabetes at every stage, including prevention, diagnosis, and treatment.
Co-Sponsored by the American Association for the Study of Liver Diseases (AASLD)
The 2021 AACE Advanced Diabetes Technology Guideline is a comprehensive, evidence based clinical practice guideline addressing the latest advancements in technology options for patients with diabetes. Key recommendations include key metrics for Continuous Glucose Monitoring (CGM), integration of technology with insulin pumps, and what health care professionals need to know in terms of safety.
The 2021 AACE Advanced Diabetes Technology Guideline is a comprehensive, evidence based clinical practice guideline addressing the latest advancements in technology options for patients with diabetes. Key recommendations include key metrics for Continuous Glucose Monitoring (CGM), integration of technology with insulin pumps, and what health care professionals need to know in terms of safety.
This algorithm for the comprehensive management of persons with type 2 diabetes (T2D) was developed to provide clinicians with a practical guide that considers the whole patient, his or her spectrum of risks and complications, and evidence-based approaches to treatment.
In this 50-minute video presentation Dr. Pop-Busiu discusses diabetic neuropathies, evidence-based prevention and management strategies, current epidemiology trends and more.
Epidemiologic data have demonstrated significant increases of various cancers in people with obesity and diabetes.
Diabetes is an increasingly prevalent diagnosis among hospitalized patients.
Many patients have unrecognized diabetes.
Endocrine Practice, our official journal, keeps you on the leading edge of endocrine patient care.
Access a wide range of case reports, visual vignettes and commentary from noted endocrinology experts.
October 14, 2022
Building off of last year’s successful new format, AACE is pleased to announce the newest edition of the AACE Self-Assessment Program (ASAP)!
October 5, 2022
In February, 2022, AACE supported an urgent call for action to address the serious health delivery issues that patients with diabetes were facing in the Tigray Region of Ethiopia as a result of the ongoing conflict between the Federal Government and the Tigray Regional Government. We are deeply concerned about the ongoing barriers to delivering life-saving supplies and medications to innocent people of Tigray, suffering with diabetes. Read our full statement to learn more.
Our updated guideline for the care and management of people with or at risk for diabetes mellitus. The guideline features 170 updated and new evidence-based clinical practice recommendations for diabetes at every stage, including prevention, diagnosis, and treatment.
A position statement by the American Association of Clinical Endocrinologists
Since its inception, the American Association of Clinical Endocrinologists (AACE) has advocated for the finest in endocrine education and state-of-the-art health-care delivery without regard to race, ethnicity, gender, age, country of origin, economic status, lifestyle, sexual orientation or domestic living arrangements.
